Neuro-Behcet Disease and Ocular Inflammation: A Case Report and Literature Review

References

• Behçet H. Uber rezidivierende aphthose, durch ein Virus verursachte Geschwure am Mund, am Auge und am den Genitalien. Dermatologische Wochenschr. 1937;105:1152–1157.
   Google Scholar
• Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behcets disease: an international collaborative study. Br J Ophthalmol. 2007; 91(12):1579–1582.
   PubMed Web of Science ®Google Scholar
• Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. Mar 2014;121(3):785–796.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I. Behçet’s Uveitis. Middle East Afr J Ophthalmol. 2009;16:219–224.
   PubMedGoogle Scholar
• Kural-Seyahi E, Fresko I, Seyahi N, et al. Mortality and Morbidity of Behçet Syndrome. Medicine (Baltimore). 2003;82:60–76.
   PubMed Web of Science ®Google Scholar
• Kerstens FG, Turkstra F, Atalay S, van Vugt RM, Swearingen CJ, Yazici Y. Adherence to guidelines for the treatment of Behçet’s syndrome in New York and Amsterdam. Clin Exper Rheum. 2017; 35(108):55–59.
   PubMedGoogle Scholar
• International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335(8697): 1078–1080.
   PubMed Web of Science ®Google Scholar
• International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of. 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. Mar, 2014;28(3):338–347.
   PubMed Web of Science ®Google Scholar
• Wechsler B, Davatchi F, Mizushima Y, et al.; The International Study Group for Behçet’s Disease. Evaluation of diagnostic (‘classification’) criteria in Behçet’s disease- towards internationally agreed criteria. Br J Rheumatol. 1992;31(5):299–308.
   PubMedGoogle Scholar
• Uluduz D, Kurtuncu M, Yapici Z, et al. Clinical characteristics of pediatric-onset neuro-Behcet disease. Neurology. 2011;77:1900–1905.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Stanford M, et al. An Algorithm for the Diagnosis of Behçet Disease Uveitis in Adults. Ocul Immunol Inflamm. Apr 2020;14:1–10.
   Google Scholar
• Faezi ST, Paragomi P, Shahram F, et al. Clinical features of Behçet’s disease in patients without oral aphthosis. Mod Rheum. 2014; 24(4):637–639.
   PubMed Web of Science ®Google Scholar
• Haghighi AB, Pourmand R, Nikseresht AR. Neuro-Behçet Disease. Neurologist. 2005;11:80–89.
   PubMed Web of Science ®Google Scholar
• Uluduz D, Midi I, Duman T, et al. Behçet’s disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study. Rheumatology (Oxford). Apr 1, 2019;58(4):600–608.
   PubMed Web of Science ®Google Scholar
• Ideguchi H, Suda A, Takeno M, et al. Neurological manifestations of Behçet’s disease in Japan: a study of 54 patients. J Neurol. 2010;257:1012–1020.
   PubMed Web of Science ®Google Scholar
• Koné-Paut I, Chabrol B, Riss JM, Mancini J, Raybaud C, Garnier JM. Neurologic Onset of Behçets Disease: A Diagnostic Enigma in Childhood. J Child Neurol. 1997;12:237–241.
   PubMed Web of Science ®Google Scholar
• Kalra S, Silman A, Akman-Demir G, et al. Diagnosis and management of neuro-Behçets disease: international consensus recommendations. J Neurol. Sep 2014;261(9):1662–1676.
   PubMed Web of Science ®Google Scholar
• Peño IC, De Las Heras Revilla V, Carbonell BP, et al. Neurobehçet disease: clinical and demographic characteristics. Eur J Neurol. 2012;19:1224–1227.
   PubMed Web of Science ®Google Scholar
• Cakar N, Ö B, Uncu N, et al. Clinical characteristics of paediatric neuro-Behçet’s disease: a single tertiary centre experience. Clin Exp Rheumatol. 2014;Jul-Aug;32:S165–70.
   Web of Science ®Google Scholar
• Ascaso F, Rodriguez A, Cristóbal J. Cranial hypertension as first manifestation of Behcet’s disease. Doc Ophthalmol. 2002;105:291–299.
   PubMedGoogle Scholar
• Gumá A, Aguilera C, Acebes J, Arruga J, Pons L. Meningeal involvement in Behçet’s disease: MRI. Neuroradiology. 1998;40:512–515.
   PubMed Web of Science ®Google Scholar
• Shahien R, Bowirrat A. Neuro-Behçet’s disease: a report of sixteen patients. Neuropsychiatr Dis Treat. 2010;6:219–225.
   PubMed Web of Science ®Google Scholar
• Dutra LA, Gonçalves CR, Braga-Neto P, et al. Atypical manifestations in Brazilian patients with neuro-Behçet’s disease. J Neurol. 2012;259:1159–1165.
   PubMed Web of Science ®Google Scholar
• Joseph FG, Scolding NJ. Neuro‐Behçet’s disease in Caucasians: a study of 22 patients. Eur J Neurol. 2007;14:174–180.
   PubMedGoogle Scholar
• Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçets disease: evaluation of 200 patients. Brain. 1999;122:2171–2182.
   PubMed Web of Science ®Google Scholar
• Çoban O, Bahar S, Akman-Demir G, et al. Masked assessment of MRI findings: is it possible to differentiate neuro-Behçets disease from other central nervous system. Neuroradiology. 1999;41:255–260.
   PubMed Web of Science ®Google Scholar
• Al-Araji A, Kidd DP. Neuro-Behçet’s disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 2009;8:192–204.
   PubMed Web of Science ®Google Scholar
• Farahangiz S, Sarhadi S, Safari A, Borhani-Haghighi A. Magnetic resonance imaging findings and outcome of neuro-Behçet’s disease: the predictive factors. Int J Rheum Dis. Dec 2012;15(6):e142–149.
   PubMed Web of Science ®Google Scholar
• Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications in Behçets syndrome. Brain. 1999;122:2183–2194.
   PubMed Web of Science ®Google Scholar
• Schwartz R, Borok S, Goldstein M, et al. Neuroretinitis and a Unilateral Superior Hemivein Occlusion with Frosted Branch Angiitis Pattern Presenting Simultaneously in Behçets Disease. Case Rep Ophthalmol. 2016;7:141–147.
   PubMed Web of Science ®Google Scholar
• Al-Mujaini A, Wali U. Frosted branch angiitis, neuroretinitis as initial ocular manifestation in Behçet disease. Indian J Ophthalmol. 2011;59:240–241.
   PubMed Web of Science ®Google Scholar
• Noel N, Bernard R, Wechsler B, et al. Long-Term Outcome of Neuro-Behçets Disease. Arthritis Rheumatol. 2014;66:1306–1314.
   PubMed Web of Science ®Google Scholar
• Chae EJ, Do K-H, Seo JB, et al. Radiologic and Clinical Findings of Behçet Disease: comprehensive Review of Multisystemic Involvement. RadioGraphics. 2008. doi:https://doi.org/10.1148/rg.e31.
   Google Scholar
• Aguiar de Sousa D, Mestre T, Ferro JM. Cerebral venous thrombosis in Behçet’s disease: a systematic review. J Neurol. 2011;258:719–727.
   PubMedGoogle Scholar
• Daif A, Awada A, al-Rajeh S, et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke. 1995;26:1193–1195.
   PubMed Web of Science ®Google Scholar
• Shi J, Huang X, Li G, et al. Cerebral venous sinus thrombosis in Behcet’s disease: a retrospective case-control study. Clin Rheum. 2018; 37(1):51–57.
   PubMed Web of Science ®Google Scholar
• Saadoun D, Wechsler B, Resche-Rigon M, et al. Cerebral venous thrombosis in Behçet’s disease. Arthritis Rheum. 2009;61:518–526.
   PubMedGoogle Scholar
• Farah S, Al-Shubaili A, Montaser A, et al. Behçet’s syndrome: a report of 41 patients with emphasis on neurological manifestations. J Neurol Neurosurg Psychiatry. 1998;64:382–384.
   PubMed Web of Science ®Google Scholar
• Ozturk K, Soylu E, Parlak M. Dural venous sinus thrombosis: the combination of noncontrast CT, MRI and PC-MR venography to enhance accuracy. Neuroradiol J. Oct 2018;31(5):473–481.
   PubMed Web of Science ®Google Scholar
• Saposnik G, Barinagarrementeria F, Brown RD Jr, et al., American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011Apr;42(4):1158–1192.
   PubMed Web of Science ®Google Scholar
• Dinkin M, Moss HE. Should Magnetic Resonance Venography Be Performed Routinely in all Patients Undergoing Evaluation for Idiopathic Intracranial Hypertension? J Neuroophthalmol. Dec 2015;35(4):431–437.
   PubMed Web of Science ®Google Scholar
• Ozguler Y, Leccese P, Christensen R, et al. Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations. Rheumatology (Oxford). Dec 1, 2018;57(12):2200–2212.
   PubMed Web of Science ®Google Scholar
• Ho CL, Deruytter MJ. Manifestations of Neuro-Behcet’s disease. Report of two cases and review of the literature. Clin Neurol and Neurosurg. 2005; 107(4):310–314.
   PubMed Web of Science ®Google Scholar
• Bitik B, Tufan A, Sahin K, et al. The association between the parenchymal neurological involvement and posterior uveitis in Behçet’s syndrome. Clin Exp Rheumatol. 2016;34:82–85.
   PubMed Web of Science ®Google Scholar
• Gheita TA, Gamal SM, Shaker I, et al. Clinical significance of serum interleukin-23 and A/G gene (rs17375018) polymorphism in Behçets disease: relation to neuro-Behçet, uveitis and disease activity. Joint Bone Spine. 2015;82:213–215.
   PubMed Web of Science ®Google Scholar
• Mora P, Menozzi C, Orsoni JG, Rubino P, Ruffini L, Carta A. Neuro-Behçet’s disease in childhood: a focus on the neuro-ophthalmological features. Orphanet J Rare Dis. Jan 2013;8:18.
   PubMed Web of Science ®Google Scholar
• Citirik M, Berker N, Songur MS, Soykan E, Zilelioglu O. Ocular findings in childhood-onset Behçet disease. J Aapos. 2009;13:391–395.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Urgancioglu M. Childhood-onset uveitis in Behçet disease: A descriptive study of 36 cases. Am J Ophthalmol. Dec 2003;136(6):1114–1119.
   PubMed Web of Science ®Google Scholar
• Kansu T, Kadayifcilar S. Visual aspects of Behçet’s disease. Curr Neurol Neurosci Rep. Sep 2005;5(5):382–388.
   PubMedGoogle Scholar
• Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. Jun 2018;77(6):808–818.
   PubMed Web of Science ®Google Scholar
• Yazici H, Pazarli H, Barnes CG, et al. A controlled trial of azathioprine in Behçet’s syndrome. N Engl J Med Overseas Ed. 1990;322:281–285.
   PubMed Web of Science ®Google Scholar
• Masuda K, Nakajima A, Urayama A, et al. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet’s disease. Lancet. 1989;1:1093–1096.
   PubMed Web of Science ®Google Scholar
• Wechsler B, Bodaghi B, Thi Huong DL, et al. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet’s disease. Ocul Immunol Inflamm. 2000;8:293–301.
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Theodossiadis PG, Katsiari CG, et al. Effect of infliximab on sight-threatening panuveitis in Behçet’s disease. Lancet. 2001;358:295–296.
   PubMed Web of Science ®Google Scholar
• Calgüneri M, Oztürk MA, Ertenli I, et al. Effects of interferon alpha treatment on the clinical course of refractory Behçet’s disease: an open study. Ann Rheum Dis. 2003;62:492–493.
   PubMed Web of Science ®Google Scholar
• Krause L, Turnbull JR, Torun N, et al. Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet’s disease. Adv Exp Med Biol. 2003;528:511–519.
   PubMed Web of Science ®Google Scholar
• Kötter I, Zierhut M, Eckstein A, et al. Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet’s disease with sight-threatening retinal vasculitis. Adv Exp Med Biol. 2003;528:521–523.
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Kaklamanis PH, Elezoglou A, et al. Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease. Ann Intern Med. 2004;140:404–406.
   PubMed Web of Science ®Google Scholar
• Ohno S, Nakamura S, Hori S, et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet’s disease with refractory uveoretinitis. J Rheumatol. 2004;31:1362–1368.
   PubMed Web of Science ®Google Scholar
• Lindstedt EW, Baarsma GS, Kuijpers RW, et al. Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol. 2005;89:533–536.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Abboud EB, Aldibhi H, et al. Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet’s disease. Int Ophthalmol. 2006;26:83–92.
   Google Scholar
• Tugal-Tutkun I, Mudun A, Urgancioglu M, et al. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet’s disease: an open-label trial. Arthritis Rheum. 2005;52:2478–2484.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Güney-Tefekli E, Urgancioglu M. Results of interferon-alfa therapy in patients with Behçet uveitis. Graefes Arch Clin Exp Ophthalmol. 2006;244:1692–1695.
   PubMed Web of Science ®Google Scholar
• Kotter I, Gunaydin I, Batra M, et al. CNS involvement occurs more frequently in patients with Behçet’s disease under cyclosporin A (CSA) than under other medications- results of a retrospective analysis of 117 cases. Clin Rheumatol. Jul 2006;25(4):482–486.
   PubMed Web of Science ®Google Scholar
• Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H. Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology. Mar 1999;106(3):586–589.
   PubMed Web of Science ®Google Scholar
• Bitik B, Ucar M, Tezcan ME, et al. Transverse myelitis in Behçet’s disease: a series of four cases and review of the literature. Clin Exper Rheumatol. 2013; 31(3):20–24.
   PubMed Web of Science ®Google Scholar
• Ferreira BFA, Rodriguez EEC, Prado LLD, Goncalves CR, Hirata CE, Yamamoto JH. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behcet’s disease: a case report and review of the literature. J Med Case Rep. Apr 15, 2017;11(1):104.
   PubMedGoogle Scholar
• Ramachandran R, Hughes E, Larkin G, Graham E, Stanford M, Lim M. Secondary frosted branch angiitis in Neuro-Behçets disease with serous macular detachment. Pediatr Int. Apr 2011;53(2):285–286.
   PubMed Web of Science ®Google Scholar
• Portero A, Herreras J. Frosted Branch Angiitis Diagnosed as Neuro-Behçet: A Diagnostic and Etiologic Dilemma. Case Rep Ophthalmol. 2011 May;2(2):170–175.
   PubMedGoogle Scholar
• Daoudi S, Lounis M, Ait-Kaci-Ahmed M. Parenchymal neuro-Behcet’s disease. Clinical and paraclinical characteristics, a report of 40 cases. Presse Med. May 2014;43(5):e119–25.
   PubMedGoogle Scholar
• Tali ET, Atilla S, Keskin T, Simonson T, Işik S, Yuh WT. MRI in neuro-Behçet’s disease. Neuroradiology. Jan 1997;39(1):2–6.
   PubMed Web of Science ®Google Scholar